nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2D6—Lomustine—brain cancer	0.139	0.303	CbGbCtD
Escitalopram—CYP2D6—Hydroxyurea—brain cancer	0.105	0.23	CbGbCtD
Escitalopram—CYP3A4—Temozolomide—brain cancer	0.104	0.227	CbGbCtD
Escitalopram—CYP3A4—Lomustine—brain cancer	0.0883	0.193	CbGbCtD
Escitalopram—HTR2C—choroid plexus—brain cancer	0.0263	0.18	CbGeAlD
Escitalopram—CYP3A4—Etoposide—brain cancer	0.0213	0.0466	CbGbCtD
Escitalopram—HRH1—nose—brain cancer	0.0102	0.0696	CbGeAlD
Escitalopram—SLC6A3—telencephalic ventricle—brain cancer	0.00797	0.0545	CbGeAlD
Escitalopram—HTR2C—telencephalic ventricle—brain cancer	0.00771	0.0527	CbGeAlD
Escitalopram—SLC6A3—ganglion—brain cancer	0.00496	0.0339	CbGeAlD
Escitalopram—HTR2C—ganglion—brain cancer	0.0048	0.0328	CbGeAlD
Escitalopram—SLC6A4—ganglion—brain cancer	0.00455	0.0311	CbGeAlD
Escitalopram—SLC6A2—ganglion—brain cancer	0.00401	0.0274	CbGeAlD
Escitalopram—SLC6A3—hindbrain—brain cancer	0.00376	0.0257	CbGeAlD
Escitalopram—SLC6A4—hindbrain—brain cancer	0.00345	0.0236	CbGeAlD
Escitalopram—ADRA1A—hindbrain—brain cancer	0.00282	0.0193	CbGeAlD
Escitalopram—SLC6A3—brainstem—brain cancer	0.00216	0.0147	CbGeAlD
Escitalopram—HTR2C—brainstem—brain cancer	0.00209	0.0143	CbGeAlD
Escitalopram—SLC6A4—brainstem—brain cancer	0.00198	0.0135	CbGeAlD
Escitalopram—SLC6A3—telencephalon—brain cancer	0.00192	0.0131	CbGeAlD
Escitalopram—HTR2C—telencephalon—brain cancer	0.00185	0.0126	CbGeAlD
Escitalopram—SLC6A4—telencephalon—brain cancer	0.00175	0.012	CbGeAlD
Escitalopram—CHRM1—telencephalon—brain cancer	0.00175	0.0119	CbGeAlD
Escitalopram—SLC6A2—brainstem—brain cancer	0.00174	0.0119	CbGeAlD
Escitalopram—CYP2D6—hindbrain—brain cancer	0.00166	0.0114	CbGeAlD
Escitalopram—ADRA1A—brainstem—brain cancer	0.00162	0.0111	CbGeAlD
Escitalopram—SLC6A2—telencephalon—brain cancer	0.00154	0.0106	CbGeAlD
Escitalopram—HTR2C—medulla oblongata—brain cancer	0.00145	0.00994	CbGeAlD
Escitalopram—ADRA1A—telencephalon—brain cancer	0.00144	0.00981	CbGeAlD
Escitalopram—SLC6A3—midbrain—brain cancer	0.00138	0.0094	CbGeAlD
Escitalopram—SLC6A3—spinal cord—brain cancer	0.00134	0.00917	CbGeAlD
Escitalopram—HTR2C—midbrain—brain cancer	0.00133	0.00908	CbGeAlD
Escitalopram—HTR2C—spinal cord—brain cancer	0.0013	0.00886	CbGeAlD
Escitalopram—SLC6A2—gonad—brain cancer	0.00129	0.00881	CbGeAlD
Escitalopram—SLC6A4—midbrain—brain cancer	0.00126	0.00861	CbGeAlD
Escitalopram—SLC6A4—spinal cord—brain cancer	0.00123	0.0084	CbGeAlD
Escitalopram—SLC6A2—medulla oblongata—brain cancer	0.00121	0.00829	CbGeAlD
Escitalopram—SLC6A3—head—brain cancer	0.00119	0.00815	CbGeAlD
Escitalopram—HTR2C—head—brain cancer	0.00115	0.00787	CbGeAlD
Escitalopram—HRH1—telencephalon—brain cancer	0.00111	0.0076	CbGeAlD
Escitalopram—SLC6A4—endocrine gland—brain cancer	0.00111	0.00756	CbGeAlD
Escitalopram—CHRM1—endocrine gland—brain cancer	0.0011	0.00753	CbGeAlD
Escitalopram—SLC6A4—head—brain cancer	0.00109	0.00747	CbGeAlD
Escitalopram—CHRM1—head—brain cancer	0.00109	0.00744	CbGeAlD
Escitalopram—SLC6A3—central nervous system—brain cancer	0.00109	0.00744	CbGeAlD
Escitalopram—SLC6A3—cerebellum—brain cancer	0.00106	0.00727	CbGeAlD
Escitalopram—HTR2C—central nervous system—brain cancer	0.00105	0.00719	CbGeAlD
Escitalopram—SLC6A4—central nervous system—brain cancer	0.000997	0.00681	CbGeAlD
Escitalopram—CHRM1—central nervous system—brain cancer	0.000994	0.00679	CbGeAlD
Escitalopram—SLC6A2—endocrine gland—brain cancer	0.000974	0.00666	CbGeAlD
Escitalopram—SLC6A2—head—brain cancer	0.000962	0.00657	CbGeAlD
Escitalopram—CYP2D6—brainstem—brain cancer	0.000953	0.00651	CbGeAlD
Escitalopram—CYP2C19—endocrine gland—brain cancer	0.000917	0.00627	CbGeAlD
Escitalopram—ADRA1A—endocrine gland—brain cancer	0.000906	0.00619	CbGeAlD
Escitalopram—ADRA1A—head—brain cancer	0.000894	0.00611	CbGeAlD
Escitalopram—SLC6A2—central nervous system—brain cancer	0.000878	0.006	CbGeAlD
Escitalopram—SLC6A3—brain—brain cancer	0.000864	0.0059	CbGeAlD
Escitalopram—CYP2D6—telencephalon—brain cancer	0.000846	0.00578	CbGeAlD
Escitalopram—HTR2C—brain—brain cancer	0.000835	0.00571	CbGeAlD
Escitalopram—ADRA1A—central nervous system—brain cancer	0.000816	0.00558	CbGeAlD
Escitalopram—ADRA1A—cerebellum—brain cancer	0.000798	0.00545	CbGeAlD
Escitalopram—SLC6A4—brain—brain cancer	0.000792	0.00541	CbGeAlD
Escitalopram—CHRM1—brain—brain cancer	0.000789	0.00539	CbGeAlD
Escitalopram—HRH1—endocrine gland—brain cancer	0.000701	0.00479	CbGeAlD
Escitalopram—SLC6A2—brain—brain cancer	0.000697	0.00476	CbGeAlD
Escitalopram—HRH1—head—brain cancer	0.000692	0.00473	CbGeAlD
Escitalopram—ADRA1A—brain—brain cancer	0.000648	0.00443	CbGeAlD
Escitalopram—HRH1—central nervous system—brain cancer	0.000632	0.00432	CbGeAlD
Escitalopram—CYP3A4—endocrine gland—brain cancer	0.000542	0.0037	CbGeAlD
Escitalopram—CYP2D6—endocrine gland—brain cancer	0.000534	0.00365	CbGeAlD
Escitalopram—CYP2D6—head—brain cancer	0.000527	0.0036	CbGeAlD
Escitalopram—HRH1—brain—brain cancer	0.000502	0.00343	CbGeAlD
Escitalopram—CYP3A4—central nervous system—brain cancer	0.000489	0.00334	CbGeAlD
Escitalopram—CYP2D6—central nervous system—brain cancer	0.000481	0.00328	CbGeAlD
Escitalopram—CYP2D6—cerebellum—brain cancer	0.00047	0.00321	CbGeAlD
Escitalopram—Fatigue—Procarbazine—brain cancer	0.000401	0.00112	CcSEcCtD
Escitalopram—Haemoglobin—Temozolomide—brain cancer	0.000398	0.00111	CcSEcCtD
Escitalopram—Malaise—Hydroxyurea—brain cancer	0.000398	0.00111	CcSEcCtD
Escitalopram—Constipation—Procarbazine—brain cancer	0.000398	0.00111	CcSEcCtD
Escitalopram—Pain—Procarbazine—brain cancer	0.000398	0.00111	CcSEcCtD
Escitalopram—Haemorrhage—Temozolomide—brain cancer	0.000396	0.0011	CcSEcCtD
Escitalopram—Hepatitis—Temozolomide—brain cancer	0.000396	0.0011	CcSEcCtD
Escitalopram—Dysphagia—Etoposide—brain cancer	0.000396	0.0011	CcSEcCtD
Escitalopram—Leukopenia—Hydroxyurea—brain cancer	0.000395	0.0011	CcSEcCtD
Escitalopram—Visual impairment—Carmustine—brain cancer	0.000395	0.0011	CcSEcCtD
Escitalopram—Hallucination—Temozolomide—brain cancer	0.000394	0.0011	CcSEcCtD
Escitalopram—Hypoaesthesia—Temozolomide—brain cancer	0.000394	0.0011	CcSEcCtD
Escitalopram—Pharyngitis—Temozolomide—brain cancer	0.000393	0.00109	CcSEcCtD
Escitalopram—Urinary tract disorder—Temozolomide—brain cancer	0.000391	0.00109	CcSEcCtD
Escitalopram—Oedema peripheral—Temozolomide—brain cancer	0.00039	0.00109	CcSEcCtD
Escitalopram—Bronchospasm—Etoposide—brain cancer	0.000389	0.00108	CcSEcCtD
Escitalopram—Connective tissue disorder—Temozolomide—brain cancer	0.000389	0.00108	CcSEcCtD
Escitalopram—Urethral disorder—Temozolomide—brain cancer	0.000388	0.00108	CcSEcCtD
Escitalopram—Sweating increased—Etoposide—brain cancer	0.000386	0.00107	CcSEcCtD
Escitalopram—Feeling abnormal—Procarbazine—brain cancer	0.000384	0.00107	CcSEcCtD
Escitalopram—Eye disorder—Carmustine—brain cancer	0.000383	0.00107	CcSEcCtD
Escitalopram—Convulsion—Hydroxyurea—brain cancer	0.000382	0.00106	CcSEcCtD
Escitalopram—CYP2D6—brain—brain cancer	0.000382	0.00261	CbGeAlD
Escitalopram—Visual impairment—Temozolomide—brain cancer	0.000382	0.00106	CcSEcCtD
Escitalopram—Gastrointestinal pain—Procarbazine—brain cancer	0.000381	0.00106	CcSEcCtD
Escitalopram—Flushing—Carmustine—brain cancer	0.00038	0.00106	CcSEcCtD
Escitalopram—Pancytopenia—Etoposide—brain cancer	0.000376	0.00105	CcSEcCtD
Escitalopram—Erythema multiforme—Temozolomide—brain cancer	0.000375	0.00104	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000373	0.00104	CcSEcCtD
Escitalopram—Discomfort—Hydroxyurea—brain cancer	0.000371	0.00103	CcSEcCtD
Escitalopram—Eye disorder—Temozolomide—brain cancer	0.00037	0.00103	CcSEcCtD
Escitalopram—Urticaria—Procarbazine—brain cancer	0.00037	0.00103	CcSEcCtD
Escitalopram—Tinnitus—Temozolomide—brain cancer	0.000369	0.00103	CcSEcCtD
Escitalopram—Body temperature increased—Procarbazine—brain cancer	0.000368	0.00102	CcSEcCtD
Escitalopram—Abdominal pain—Procarbazine—brain cancer	0.000368	0.00102	CcSEcCtD
Escitalopram—Flushing—Temozolomide—brain cancer	0.000368	0.00102	CcSEcCtD
Escitalopram—Cardiac disorder—Temozolomide—brain cancer	0.000368	0.00102	CcSEcCtD
Escitalopram—Arrhythmia—Carmustine—brain cancer	0.000366	0.00102	CcSEcCtD
Escitalopram—Alopecia—Carmustine—brain cancer	0.000362	0.00101	CcSEcCtD
Escitalopram—Oedema—Hydroxyurea—brain cancer	0.00036	0.001	CcSEcCtD
Escitalopram—Angiopathy—Temozolomide—brain cancer	0.000359	0.001	CcSEcCtD
Escitalopram—Mental disorder—Carmustine—brain cancer	0.000359	0.001	CcSEcCtD
Escitalopram—Infection—Hydroxyurea—brain cancer	0.000358	0.000996	CcSEcCtD
Escitalopram—Immune system disorder—Temozolomide—brain cancer	0.000358	0.000996	CcSEcCtD
Escitalopram—Mediastinal disorder—Temozolomide—brain cancer	0.000357	0.000994	CcSEcCtD
Escitalopram—Erythema—Carmustine—brain cancer	0.000357	0.000993	CcSEcCtD
Escitalopram—Malnutrition—Carmustine—brain cancer	0.000357	0.000993	CcSEcCtD
Escitalopram—Chills—Temozolomide—brain cancer	0.000355	0.000989	CcSEcCtD
Escitalopram—Pneumonia—Etoposide—brain cancer	0.000355	0.000989	CcSEcCtD
Escitalopram—Nervous system disorder—Hydroxyurea—brain cancer	0.000353	0.000983	CcSEcCtD
Escitalopram—Infestation NOS—Etoposide—brain cancer	0.000353	0.000983	CcSEcCtD
Escitalopram—Infestation—Etoposide—brain cancer	0.000353	0.000983	CcSEcCtD
Escitalopram—Thrombocytopenia—Hydroxyurea—brain cancer	0.000353	0.000982	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00035	0.000974	CcSEcCtD
Escitalopram—Alopecia—Temozolomide—brain cancer	0.00035	0.000974	CcSEcCtD
Escitalopram—Skin disorder—Hydroxyurea—brain cancer	0.00035	0.000974	CcSEcCtD
Escitalopram—Acute coronary syndrome—Etoposide—brain cancer	0.000348	0.000969	CcSEcCtD
Escitalopram—Mental disorder—Temozolomide—brain cancer	0.000347	0.000966	CcSEcCtD
Escitalopram—Neuropathy peripheral—Etoposide—brain cancer	0.000346	0.000963	CcSEcCtD
Escitalopram—Myocardial infarction—Etoposide—brain cancer	0.000346	0.000963	CcSEcCtD
Escitalopram—Back pain—Carmustine—brain cancer	0.000345	0.000961	CcSEcCtD
Escitalopram—Erythema—Temozolomide—brain cancer	0.000345	0.00096	CcSEcCtD
Escitalopram—Malnutrition—Temozolomide—brain cancer	0.000345	0.00096	CcSEcCtD
Escitalopram—Stomatitis—Etoposide—brain cancer	0.000344	0.000958	CcSEcCtD
Escitalopram—Jaundice—Etoposide—brain cancer	0.000344	0.000958	CcSEcCtD
Escitalopram—Anorexia—Hydroxyurea—brain cancer	0.000343	0.000956	CcSEcCtD
Escitalopram—Hypersensitivity—Procarbazine—brain cancer	0.000343	0.000955	CcSEcCtD
Escitalopram—Dysgeusia—Temozolomide—brain cancer	0.000338	0.00094	CcSEcCtD
Escitalopram—Vision blurred—Carmustine—brain cancer	0.000336	0.000936	CcSEcCtD
Escitalopram—Tremor—Carmustine—brain cancer	0.000334	0.000931	CcSEcCtD
Escitalopram—Asthenia—Procarbazine—brain cancer	0.000334	0.00093	CcSEcCtD
Escitalopram—Hepatobiliary disease—Etoposide—brain cancer	0.000334	0.00093	CcSEcCtD
Escitalopram—Back pain—Temozolomide—brain cancer	0.000334	0.000928	CcSEcCtD
Escitalopram—Anaemia—Carmustine—brain cancer	0.00033	0.000918	CcSEcCtD
Escitalopram—Agranulocytosis—Etoposide—brain cancer	0.000329	0.000917	CcSEcCtD
Escitalopram—Pruritus—Procarbazine—brain cancer	0.000329	0.000917	CcSEcCtD
Escitalopram—Agitation—Carmustine—brain cancer	0.000328	0.000913	CcSEcCtD
Escitalopram—Vision blurred—Temozolomide—brain cancer	0.000325	0.000905	CcSEcCtD
Escitalopram—Tremor—Temozolomide—brain cancer	0.000323	0.000899	CcSEcCtD
Escitalopram—Dyspnoea—Hydroxyurea—brain cancer	0.000321	0.000894	CcSEcCtD
Escitalopram—Somnolence—Hydroxyurea—brain cancer	0.00032	0.000891	CcSEcCtD
Escitalopram—Ill-defined disorder—Temozolomide—brain cancer	0.00032	0.000891	CcSEcCtD
Escitalopram—Leukopenia—Carmustine—brain cancer	0.000319	0.000889	CcSEcCtD
Escitalopram—Anaemia—Temozolomide—brain cancer	0.000319	0.000887	CcSEcCtD
Escitalopram—Diarrhoea—Procarbazine—brain cancer	0.000318	0.000887	CcSEcCtD
Escitalopram—Dyspepsia—Hydroxyurea—brain cancer	0.000317	0.000883	CcSEcCtD
Escitalopram—Agitation—Temozolomide—brain cancer	0.000317	0.000882	CcSEcCtD
Escitalopram—Hypoaesthesia—Etoposide—brain cancer	0.000315	0.000878	CcSEcCtD
Escitalopram—Angioedema—Temozolomide—brain cancer	0.000315	0.000877	CcSEcCtD
Escitalopram—Decreased appetite—Hydroxyurea—brain cancer	0.000313	0.000872	CcSEcCtD
Escitalopram—Urinary tract disorder—Etoposide—brain cancer	0.000313	0.000871	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000311	0.000866	CcSEcCtD
Escitalopram—Malaise—Temozolomide—brain cancer	0.000311	0.000866	CcSEcCtD
Escitalopram—Urethral disorder—Etoposide—brain cancer	0.000311	0.000865	CcSEcCtD
Escitalopram—Fatigue—Hydroxyurea—brain cancer	0.000311	0.000865	CcSEcCtD
Escitalopram—Vertigo—Temozolomide—brain cancer	0.00031	0.000862	CcSEcCtD
Escitalopram—Convulsion—Carmustine—brain cancer	0.000309	0.000861	CcSEcCtD
Escitalopram—Leukopenia—Temozolomide—brain cancer	0.000309	0.000859	CcSEcCtD
Escitalopram—Hypertension—Carmustine—brain cancer	0.000308	0.000858	CcSEcCtD
Escitalopram—Constipation—Hydroxyurea—brain cancer	0.000308	0.000858	CcSEcCtD
Escitalopram—Pain—Hydroxyurea—brain cancer	0.000308	0.000858	CcSEcCtD
Escitalopram—Dizziness—Procarbazine—brain cancer	0.000308	0.000857	CcSEcCtD
Escitalopram—Palpitations—Temozolomide—brain cancer	0.000305	0.000848	CcSEcCtD
Escitalopram—Myalgia—Carmustine—brain cancer	0.000304	0.000846	CcSEcCtD
Escitalopram—Chest pain—Carmustine—brain cancer	0.000304	0.000846	CcSEcCtD
Escitalopram—Anxiety—Carmustine—brain cancer	0.000303	0.000843	CcSEcCtD
Escitalopram—Cough—Temozolomide—brain cancer	0.000301	0.000838	CcSEcCtD
Escitalopram—Erythema multiforme—Etoposide—brain cancer	0.0003	0.000834	CcSEcCtD
Escitalopram—Convulsion—Temozolomide—brain cancer	0.000299	0.000832	CcSEcCtD
Escitalopram—Hypertension—Temozolomide—brain cancer	0.000298	0.000829	CcSEcCtD
Escitalopram—Feeling abnormal—Hydroxyurea—brain cancer	0.000297	0.000826	CcSEcCtD
Escitalopram—Eye disorder—Etoposide—brain cancer	0.000296	0.000825	CcSEcCtD
Escitalopram—Vomiting—Procarbazine—brain cancer	0.000296	0.000824	CcSEcCtD
Escitalopram—Cardiac disorder—Etoposide—brain cancer	0.000294	0.000819	CcSEcCtD
Escitalopram—Flushing—Etoposide—brain cancer	0.000294	0.000819	CcSEcCtD
Escitalopram—Confusional state—Carmustine—brain cancer	0.000294	0.000817	CcSEcCtD
Escitalopram—Myalgia—Temozolomide—brain cancer	0.000294	0.000817	CcSEcCtD
Escitalopram—Arthralgia—Temozolomide—brain cancer	0.000294	0.000817	CcSEcCtD
Escitalopram—Rash—Procarbazine—brain cancer	0.000293	0.000817	CcSEcCtD
Escitalopram—Dermatitis—Procarbazine—brain cancer	0.000293	0.000816	CcSEcCtD
Escitalopram—Anxiety—Temozolomide—brain cancer	0.000293	0.000814	CcSEcCtD
Escitalopram—Headache—Procarbazine—brain cancer	0.000292	0.000812	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000292	0.000812	CcSEcCtD
Escitalopram—Oedema—Carmustine—brain cancer	0.000291	0.000811	CcSEcCtD
Escitalopram—Discomfort—Temozolomide—brain cancer	0.00029	0.000807	CcSEcCtD
Escitalopram—Infection—Carmustine—brain cancer	0.000289	0.000805	CcSEcCtD
Escitalopram—Angiopathy—Etoposide—brain cancer	0.000288	0.000801	CcSEcCtD
Escitalopram—Dry mouth—Temozolomide—brain cancer	0.000287	0.000799	CcSEcCtD
Escitalopram—Immune system disorder—Etoposide—brain cancer	0.000286	0.000797	CcSEcCtD
Escitalopram—Mediastinal disorder—Etoposide—brain cancer	0.000286	0.000795	CcSEcCtD
Escitalopram—Thrombocytopenia—Carmustine—brain cancer	0.000285	0.000794	CcSEcCtD
Escitalopram—Body temperature increased—Hydroxyurea—brain cancer	0.000285	0.000793	CcSEcCtD
Escitalopram—Chills—Etoposide—brain cancer	0.000284	0.000792	CcSEcCtD
Escitalopram—Tachycardia—Carmustine—brain cancer	0.000284	0.000791	CcSEcCtD
Escitalopram—Confusional state—Temozolomide—brain cancer	0.000284	0.00079	CcSEcCtD
Escitalopram—Anaphylactic shock—Temozolomide—brain cancer	0.000281	0.000783	CcSEcCtD
Escitalopram—Oedema—Temozolomide—brain cancer	0.000281	0.000783	CcSEcCtD
Escitalopram—Alopecia—Etoposide—brain cancer	0.00028	0.00078	CcSEcCtD
Escitalopram—Infection—Temozolomide—brain cancer	0.00028	0.000778	CcSEcCtD
Escitalopram—Anorexia—Carmustine—brain cancer	0.000278	0.000773	CcSEcCtD
Escitalopram—Nausea—Procarbazine—brain cancer	0.000276	0.00077	CcSEcCtD
Escitalopram—Nervous system disorder—Temozolomide—brain cancer	0.000276	0.000768	CcSEcCtD
Escitalopram—Thrombocytopenia—Temozolomide—brain cancer	0.000276	0.000767	CcSEcCtD
Escitalopram—Skin disorder—Temozolomide—brain cancer	0.000273	0.000761	CcSEcCtD
Escitalopram—Hypotension—Carmustine—brain cancer	0.000272	0.000757	CcSEcCtD
Escitalopram—Hyperhidrosis—Temozolomide—brain cancer	0.000272	0.000757	CcSEcCtD
Escitalopram—Dysgeusia—Etoposide—brain cancer	0.00027	0.000752	CcSEcCtD
Escitalopram—Anorexia—Temozolomide—brain cancer	0.000268	0.000747	CcSEcCtD
Escitalopram—Back pain—Etoposide—brain cancer	0.000267	0.000743	CcSEcCtD
Escitalopram—Hypersensitivity—Hydroxyurea—brain cancer	0.000265	0.000739	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Carmustine—brain cancer	0.000265	0.000739	CcSEcCtD
Escitalopram—Muscle spasms—Etoposide—brain cancer	0.000265	0.000738	CcSEcCtD
Escitalopram—Insomnia—Carmustine—brain cancer	0.000263	0.000733	CcSEcCtD
Escitalopram—Paraesthesia—Carmustine—brain cancer	0.000261	0.000728	CcSEcCtD
Escitalopram—Dyspnoea—Carmustine—brain cancer	0.00026	0.000723	CcSEcCtD
Escitalopram—Somnolence—Carmustine—brain cancer	0.000259	0.000721	CcSEcCtD
Escitalopram—Asthenia—Hydroxyurea—brain cancer	0.000258	0.000719	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000256	0.000714	CcSEcCtD
Escitalopram—Ill-defined disorder—Etoposide—brain cancer	0.000256	0.000713	CcSEcCtD
Escitalopram—Anaemia—Etoposide—brain cancer	0.000255	0.00071	CcSEcCtD
Escitalopram—Insomnia—Temozolomide—brain cancer	0.000255	0.000709	CcSEcCtD
Escitalopram—Decreased appetite—Carmustine—brain cancer	0.000253	0.000705	CcSEcCtD
Escitalopram—Paraesthesia—Temozolomide—brain cancer	0.000253	0.000703	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Carmustine—brain cancer	0.000251	0.0007	CcSEcCtD
Escitalopram—Dyspnoea—Temozolomide—brain cancer	0.000251	0.000698	CcSEcCtD
Escitalopram—Somnolence—Temozolomide—brain cancer	0.00025	0.000696	CcSEcCtD
Escitalopram—Constipation—Carmustine—brain cancer	0.000249	0.000693	CcSEcCtD
Escitalopram—Pain—Carmustine—brain cancer	0.000249	0.000693	CcSEcCtD
Escitalopram—Malaise—Etoposide—brain cancer	0.000249	0.000693	CcSEcCtD
Escitalopram—Vertigo—Etoposide—brain cancer	0.000248	0.00069	CcSEcCtD
Escitalopram—Dyspepsia—Temozolomide—brain cancer	0.000248	0.00069	CcSEcCtD
Escitalopram—Leukopenia—Etoposide—brain cancer	0.000247	0.000688	CcSEcCtD
Escitalopram—Diarrhoea—Hydroxyurea—brain cancer	0.000246	0.000686	CcSEcCtD
Escitalopram—Decreased appetite—Temozolomide—brain cancer	0.000245	0.000681	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Temozolomide—brain cancer	0.000243	0.000676	CcSEcCtD
Escitalopram—Fatigue—Temozolomide—brain cancer	0.000243	0.000675	CcSEcCtD
Escitalopram—Loss of consciousness—Etoposide—brain cancer	0.000243	0.000675	CcSEcCtD
Escitalopram—Cough—Etoposide—brain cancer	0.000241	0.00067	CcSEcCtD
Escitalopram—Constipation—Temozolomide—brain cancer	0.000241	0.00067	CcSEcCtD
Escitalopram—Pain—Temozolomide—brain cancer	0.000241	0.00067	CcSEcCtD
Escitalopram—Feeling abnormal—Carmustine—brain cancer	0.00024	0.000668	CcSEcCtD
Escitalopram—Convulsion—Etoposide—brain cancer	0.000239	0.000666	CcSEcCtD
Escitalopram—Hypertension—Etoposide—brain cancer	0.000238	0.000663	CcSEcCtD
Escitalopram—Dizziness—Hydroxyurea—brain cancer	0.000238	0.000663	CcSEcCtD
Escitalopram—Gastrointestinal pain—Carmustine—brain cancer	0.000238	0.000663	CcSEcCtD
Escitalopram—Chest pain—Etoposide—brain cancer	0.000235	0.000654	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000233	0.000649	CcSEcCtD
Escitalopram—Discomfort—Etoposide—brain cancer	0.000232	0.000646	CcSEcCtD
Escitalopram—Feeling abnormal—Temozolomide—brain cancer	0.000232	0.000646	CcSEcCtD
Escitalopram—Abdominal pain—Carmustine—brain cancer	0.00023	0.000641	CcSEcCtD
Escitalopram—Body temperature increased—Carmustine—brain cancer	0.00023	0.000641	CcSEcCtD
Escitalopram—Gastrointestinal pain—Temozolomide—brain cancer	0.00023	0.000641	CcSEcCtD
Escitalopram—Vomiting—Hydroxyurea—brain cancer	0.000229	0.000638	CcSEcCtD
Escitalopram—Rash—Hydroxyurea—brain cancer	0.000227	0.000632	CcSEcCtD
Escitalopram—Confusional state—Etoposide—brain cancer	0.000227	0.000632	CcSEcCtD
Escitalopram—Dermatitis—Hydroxyurea—brain cancer	0.000227	0.000632	CcSEcCtD
Escitalopram—Headache—Hydroxyurea—brain cancer	0.000226	0.000628	CcSEcCtD
Escitalopram—Anaphylactic shock—Etoposide—brain cancer	0.000225	0.000627	CcSEcCtD
Escitalopram—Infection—Etoposide—brain cancer	0.000224	0.000623	CcSEcCtD
Escitalopram—Urticaria—Temozolomide—brain cancer	0.000224	0.000622	CcSEcCtD
Escitalopram—Abdominal pain—Temozolomide—brain cancer	0.000222	0.000619	CcSEcCtD
Escitalopram—Body temperature increased—Temozolomide—brain cancer	0.000222	0.000619	CcSEcCtD
Escitalopram—Thrombocytopenia—Etoposide—brain cancer	0.00022	0.000614	CcSEcCtD
Escitalopram—Tachycardia—Etoposide—brain cancer	0.00022	0.000612	CcSEcCtD
Escitalopram—Skin disorder—Etoposide—brain cancer	0.000219	0.000609	CcSEcCtD
Escitalopram—Hyperhidrosis—Etoposide—brain cancer	0.000218	0.000606	CcSEcCtD
Escitalopram—Anorexia—Etoposide—brain cancer	0.000215	0.000598	CcSEcCtD
Escitalopram—Hypersensitivity—Carmustine—brain cancer	0.000215	0.000597	CcSEcCtD
Escitalopram—Nausea—Hydroxyurea—brain cancer	0.000214	0.000596	CcSEcCtD
Escitalopram—Hypotension—Etoposide—brain cancer	0.00021	0.000586	CcSEcCtD
Escitalopram—Asthenia—Carmustine—brain cancer	0.000209	0.000582	CcSEcCtD
Escitalopram—Hypersensitivity—Temozolomide—brain cancer	0.000207	0.000577	CcSEcCtD
Escitalopram—Paraesthesia—Etoposide—brain cancer	0.000202	0.000563	CcSEcCtD
Escitalopram—Asthenia—Temozolomide—brain cancer	0.000202	0.000562	CcSEcCtD
Escitalopram—Dyspnoea—Etoposide—brain cancer	0.000201	0.000559	CcSEcCtD
Escitalopram—Somnolence—Etoposide—brain cancer	0.0002	0.000557	CcSEcCtD
Escitalopram—Diarrhoea—Carmustine—brain cancer	0.000199	0.000555	CcSEcCtD
Escitalopram—Pruritus—Temozolomide—brain cancer	0.000199	0.000554	CcSEcCtD
Escitalopram—Decreased appetite—Etoposide—brain cancer	0.000196	0.000545	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Etoposide—brain cancer	0.000194	0.000541	CcSEcCtD
Escitalopram—Fatigue—Etoposide—brain cancer	0.000194	0.00054	CcSEcCtD
Escitalopram—Dizziness—Carmustine—brain cancer	0.000193	0.000536	CcSEcCtD
Escitalopram—Constipation—Etoposide—brain cancer	0.000193	0.000536	CcSEcCtD
Escitalopram—Pain—Etoposide—brain cancer	0.000193	0.000536	CcSEcCtD
Escitalopram—Diarrhoea—Temozolomide—brain cancer	0.000193	0.000536	CcSEcCtD
Escitalopram—Dizziness—Temozolomide—brain cancer	0.000186	0.000518	CcSEcCtD
Escitalopram—Feeling abnormal—Etoposide—brain cancer	0.000186	0.000517	CcSEcCtD
Escitalopram—Vomiting—Carmustine—brain cancer	0.000185	0.000515	CcSEcCtD
Escitalopram—Gastrointestinal pain—Etoposide—brain cancer	0.000184	0.000513	CcSEcCtD
Escitalopram—Rash—Carmustine—brain cancer	0.000184	0.000511	CcSEcCtD
Escitalopram—Dermatitis—Carmustine—brain cancer	0.000183	0.000511	CcSEcCtD
Escitalopram—Headache—Carmustine—brain cancer	0.000182	0.000508	CcSEcCtD
Escitalopram—Vomiting—Temozolomide—brain cancer	0.000179	0.000498	CcSEcCtD
Escitalopram—Urticaria—Etoposide—brain cancer	0.000179	0.000498	CcSEcCtD
Escitalopram—Body temperature increased—Etoposide—brain cancer	0.000178	0.000496	CcSEcCtD
Escitalopram—Abdominal pain—Etoposide—brain cancer	0.000178	0.000496	CcSEcCtD
Escitalopram—Rash—Temozolomide—brain cancer	0.000177	0.000494	CcSEcCtD
Escitalopram—Dermatitis—Temozolomide—brain cancer	0.000177	0.000493	CcSEcCtD
Escitalopram—Headache—Temozolomide—brain cancer	0.000176	0.000491	CcSEcCtD
Escitalopram—Nausea—Carmustine—brain cancer	0.000173	0.000482	CcSEcCtD
Escitalopram—Nausea—Temozolomide—brain cancer	0.000167	0.000465	CcSEcCtD
Escitalopram—Hypersensitivity—Etoposide—brain cancer	0.000166	0.000462	CcSEcCtD
Escitalopram—Asthenia—Etoposide—brain cancer	0.000162	0.00045	CcSEcCtD
Escitalopram—Pruritus—Etoposide—brain cancer	0.000159	0.000444	CcSEcCtD
Escitalopram—Diarrhoea—Etoposide—brain cancer	0.000154	0.000429	CcSEcCtD
Escitalopram—Dizziness—Etoposide—brain cancer	0.000149	0.000415	CcSEcCtD
Escitalopram—Vomiting—Etoposide—brain cancer	0.000143	0.000399	CcSEcCtD
Escitalopram—Rash—Etoposide—brain cancer	0.000142	0.000395	CcSEcCtD
Escitalopram—Dermatitis—Etoposide—brain cancer	0.000142	0.000395	CcSEcCtD
Escitalopram—Headache—Etoposide—brain cancer	0.000141	0.000393	CcSEcCtD
Escitalopram—Nausea—Etoposide—brain cancer	0.000134	0.000372	CcSEcCtD
Escitalopram—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	9.48e-05	0.00256	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—CYP2C9—brain cancer	9.28e-05	0.00251	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.16e-05	0.00247	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	9.14e-05	0.00247	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—SIRT1—brain cancer	7.83e-05	0.00212	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	7.75e-05	0.00209	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—SHH—brain cancer	7.52e-05	0.00203	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PTCH2—brain cancer	7.49e-05	0.00202	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—SMO—brain cancer	7.13e-05	0.00193	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—PTCH1—brain cancer	7.13e-05	0.00193	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—APC—brain cancer	7.08e-05	0.00191	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	7.08e-05	0.00191	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	6.96e-05	0.00188	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OR4C12—brain cancer	6.87e-05	0.00185	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OR14C36—brain cancer	6.87e-05	0.00185	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—VEGFA—brain cancer	6.82e-05	0.00184	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—SHH—brain cancer	6.52e-05	0.00176	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—SHH—brain cancer	6.49e-05	0.00175	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PTCH2—brain cancer	6.49e-05	0.00175	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—ABR—brain cancer	6.47e-05	0.00175	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PTCH2—brain cancer	6.47e-05	0.00175	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—SHH—brain cancer	6.39e-05	0.00173	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PTCH2—brain cancer	6.37e-05	0.00172	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—PTCH1—brain cancer	6.18e-05	0.00167	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—SMO—brain cancer	6.18e-05	0.00167	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	6.17e-05	0.00167	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—SMO—brain cancer	6.16e-05	0.00166	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—PTCH1—brain cancer	6.16e-05	0.00166	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—PTCH1—brain cancer	6.06e-05	0.00164	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—SMO—brain cancer	6.06e-05	0.00164	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OR14C36—brain cancer	5.95e-05	0.00161	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OR4C12—brain cancer	5.95e-05	0.00161	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OR4C12—brain cancer	5.93e-05	0.0016	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OR14C36—brain cancer	5.93e-05	0.0016	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.93e-05	0.0016	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—CDK4—brain cancer	5.92e-05	0.0016	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—ABR—brain cancer	5.88e-05	0.00159	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OR4C12—brain cancer	5.84e-05	0.00158	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OR14C36—brain cancer	5.84e-05	0.00158	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DTX2—brain cancer	5.84e-05	0.00158	CbGpPWpGaD
Escitalopram—ADRA1A—AMPK Signaling—TP53—brain cancer	5.83e-05	0.00158	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—ABR—brain cancer	5.61e-05	0.00151	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—ABR—brain cancer	5.59e-05	0.00151	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—ABR—brain cancer	5.5e-05	0.00149	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ABR—brain cancer	5.09e-05	0.00138	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ABR—brain cancer	5.08e-05	0.00137	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DTX2—brain cancer	5.06e-05	0.00137	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DTX2—brain cancer	5.04e-05	0.00136	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ABR—brain cancer	5e-05	0.00135	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DTX2—brain cancer	4.96e-05	0.00134	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PTCH2—brain cancer	4.42e-05	0.0012	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.33e-05	0.00117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HES5—brain cancer	4.29e-05	0.00116	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—TP53—brain cancer	4.21e-05	0.00114	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STRADA—brain cancer	4.16e-05	0.00112	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—TRPC6—brain cancer	4.1e-05	0.00111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—SHH—brain cancer	3.86e-05	0.00104	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTCH2—brain cancer	3.83e-05	0.00104	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTCH2—brain cancer	3.82e-05	0.00103	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	3.81e-05	0.00103	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTCH2—brain cancer	3.76e-05	0.00102	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TRPC6—brain cancer	3.72e-05	0.001	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HES5—brain cancer	3.71e-05	0.001	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HES5—brain cancer	3.7e-05	0.001	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—SMO—brain cancer	3.66e-05	0.000988	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PTCH1—brain cancer	3.66e-05	0.000988	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HES5—brain cancer	3.64e-05	0.000984	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STRADA—brain cancer	3.6e-05	0.000974	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STRADA—brain cancer	3.59e-05	0.00097	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—TRPC6—brain cancer	3.55e-05	0.000959	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	3.54e-05	0.000956	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STRADA—brain cancer	3.54e-05	0.000955	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	3.48e-05	0.000941	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ABR—brain cancer	3.47e-05	0.000938	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GLI2—brain cancer	3.35e-05	0.000906	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—SHH—brain cancer	3.34e-05	0.000903	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—SHH—brain cancer	3.33e-05	0.0009	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.29e-05	0.000889	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—SHH—brain cancer	3.28e-05	0.000886	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TRPC6—brain cancer	3.22e-05	0.000871	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TRPC6—brain cancer	3.21e-05	0.000868	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—SMO—brain cancer	3.17e-05	0.000856	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PTCH1—brain cancer	3.17e-05	0.000856	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	3.16e-05	0.000854	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—SMO—brain cancer	3.16e-05	0.000853	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PTCH1—brain cancer	3.16e-05	0.000853	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GLI1—brain cancer	3.15e-05	0.000852	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	3.11e-05	0.00084	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—SMO—brain cancer	3.11e-05	0.00084	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—VAV1—brain cancer	3.07e-05	0.000829	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ABR—brain cancer	3.01e-05	0.000813	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ABR—brain cancer	3e-05	0.00081	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SUFU—brain cancer	2.99e-05	0.000807	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ABR—brain cancer	2.95e-05	0.000797	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GLI2—brain cancer	2.91e-05	0.000785	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GLI2—brain cancer	2.9e-05	0.000782	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GFAP—brain cancer	2.88e-05	0.000779	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.85e-05	0.00077	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GLI2—brain cancer	2.85e-05	0.00077	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.84e-05	0.000768	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.8e-05	0.000756	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—VAV1—brain cancer	2.79e-05	0.000753	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HEY1—brain cancer	2.73e-05	0.000738	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GLI1—brain cancer	2.73e-05	0.000738	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GLI1—brain cancer	2.72e-05	0.000735	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DLL1—brain cancer	2.68e-05	0.000724	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GLI1—brain cancer	2.68e-05	0.000724	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—VAV1—brain cancer	2.66e-05	0.000718	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—VAV1—brain cancer	2.65e-05	0.000716	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2C9—brain cancer	2.64e-05	0.000713	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	2.61e-05	0.000705	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SUFU—brain cancer	2.59e-05	0.000699	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SUFU—brain cancer	2.58e-05	0.000697	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SUFU—brain cancer	2.54e-05	0.000686	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—TP53—brain cancer	2.52e-05	0.000681	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GFAP—brain cancer	2.5e-05	0.000675	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GFAP—brain cancer	2.49e-05	0.000673	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GFAP—brain cancer	2.45e-05	0.000662	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2C9—brain cancer	2.43e-05	0.000656	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—VAV1—brain cancer	2.42e-05	0.000652	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—VAV1—brain cancer	2.41e-05	0.00065	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—VAV1—brain cancer	2.37e-05	0.00064	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HEY1—brain cancer	2.37e-05	0.00064	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HEY1—brain cancer	2.36e-05	0.000638	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HEY1—brain cancer	2.32e-05	0.000628	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DLL1—brain cancer	2.32e-05	0.000627	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DLL1—brain cancer	2.32e-05	0.000625	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DLL1—brain cancer	2.28e-05	0.000616	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SHH—brain cancer	2.28e-05	0.000616	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—BSG—brain cancer	2.24e-05	0.000606	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TRPC6—brain cancer	2.2e-05	0.000594	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PTCH1—brain cancer	2.16e-05	0.000584	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SMO—brain cancer	2.16e-05	0.000584	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—BSG—brain cancer	2.06e-05	0.000558	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SHH—brain cancer	1.98e-05	0.000533	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SHH—brain cancer	1.97e-05	0.000532	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	1.95e-05	0.000526	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SHH—brain cancer	1.94e-05	0.000523	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—IDH1—brain cancer	1.93e-05	0.000521	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TRPC6—brain cancer	1.9e-05	0.000514	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TRPC6—brain cancer	1.9e-05	0.000513	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTCH1—brain cancer	1.87e-05	0.000506	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SMO—brain cancer	1.87e-05	0.000506	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TRPC6—brain cancer	1.87e-05	0.000505	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTCH1—brain cancer	1.87e-05	0.000504	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SMO—brain cancer	1.87e-05	0.000504	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SMO—brain cancer	1.84e-05	0.000496	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.84e-05	0.000496	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—IDH1—brain cancer	1.78e-05	0.000479	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.77e-05	0.000478	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.73e-05	0.000467	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.69e-05	0.000456	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.68e-05	0.000455	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.66e-05	0.000448	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VAV1—brain cancer	1.65e-05	0.000445	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2C9—brain cancer	1.59e-05	0.000429	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.57e-05	0.000424	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.53e-05	0.000414	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.53e-05	0.000413	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ENO2—brain cancer	1.53e-05	0.000412	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.51e-05	0.000407	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.5e-05	0.000404	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.49e-05	0.000403	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.47e-05	0.000397	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VAV1—brain cancer	1.43e-05	0.000385	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VAV1—brain cancer	1.42e-05	0.000384	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HES1—brain cancer	1.42e-05	0.000383	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ENO2—brain cancer	1.4e-05	0.000379	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.4e-05	0.000378	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.37e-05	0.00037	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—BSG—brain cancer	1.35e-05	0.000365	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.35e-05	0.000364	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SPP1—brain cancer	1.31e-05	0.000354	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL2—brain cancer	1.25e-05	0.000336	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HES1—brain cancer	1.23e-05	0.000331	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HES1—brain cancer	1.22e-05	0.00033	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HES1—brain cancer	1.2e-05	0.000325	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—IL2—brain cancer	1.19e-05	0.000321	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.18e-05	0.00032	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS2—brain cancer	1.18e-05	0.00032	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.17e-05	0.000316	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.17e-05	0.000315	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.16e-05	0.000315	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—IDH1—brain cancer	1.16e-05	0.000313	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.15e-05	0.00031	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SPP1—brain cancer	1.13e-05	0.000306	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SPP1—brain cancer	1.13e-05	0.000305	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.11e-05	0.000301	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL2—brain cancer	1.08e-05	0.000292	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL2—brain cancer	1.08e-05	0.000291	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.06e-05	0.000286	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APC—brain cancer	1.05e-05	0.000282	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000282	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS2—brain cancer	1.03e-05	0.000277	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS2—brain cancer	1.02e-05	0.000276	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.01e-05	0.000272	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—EGFR—brain cancer	9.53e-06	0.000257	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ENO2—brain cancer	9.18e-06	0.000248	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APC—brain cancer	9.06e-06	0.000245	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CG—brain cancer	9.06e-06	0.000245	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APC—brain cancer	9.03e-06	0.000244	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CG—brain cancer	9.03e-06	0.000244	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	8.89e-06	0.00024	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APC—brain cancer	8.89e-06	0.00024	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EGFR—brain cancer	8.26e-06	0.000223	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EGFR—brain cancer	8.23e-06	0.000222	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RELA—brain cancer	8.17e-06	0.000221	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ERBB2—brain cancer	8.12e-06	0.000219	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EGFR—brain cancer	8.1e-06	0.000219	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL2—brain cancer	7.36e-06	0.000199	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCND1—brain cancer	7.17e-06	0.000194	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CTNNB1—brain cancer	7.1e-06	0.000192	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RELA—brain cancer	7.08e-06	0.000191	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RELA—brain cancer	7.06e-06	0.000191	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ERBB2—brain cancer	7.04e-06	0.00019	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ERBB2—brain cancer	7.01e-06	0.000189	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CG—brain cancer	7e-06	0.000189	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RELA—brain cancer	6.95e-06	0.000188	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ERBB2—brain cancer	6.9e-06	0.000186	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CG—brain cancer	6.44e-06	0.000174	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL2—brain cancer	6.38e-06	0.000172	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL2—brain cancer	6.36e-06	0.000172	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL2—brain cancer	6.26e-06	0.000169	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—brain cancer	6.25e-06	0.000169	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCND1—brain cancer	6.22e-06	0.000168	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCND1—brain cancer	6.2e-06	0.000167	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—brain cancer	6.19e-06	0.000167	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CTNNB1—brain cancer	6.16e-06	0.000166	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CTNNB1—brain cancer	6.14e-06	0.000166	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCND1—brain cancer	6.1e-06	0.000165	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	6.04e-06	0.000163	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MYC—brain cancer	5.75e-06	0.000155	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EGFR—brain cancer	5.63e-06	0.000152	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—brain cancer	5.42e-06	0.000146	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—brain cancer	5.4e-06	0.000146	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—brain cancer	5.37e-06	0.000145	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—brain cancer	5.35e-06	0.000144	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—brain cancer	5.32e-06	0.000144	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—brain cancer	5.27e-06	0.000142	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MYC—brain cancer	4.99e-06	0.000135	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MYC—brain cancer	4.97e-06	0.000134	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MYC—brain cancer	4.89e-06	0.000132	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EGFR—brain cancer	4.88e-06	0.000132	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EGFR—brain cancer	4.86e-06	0.000131	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EGFR—brain cancer	4.79e-06	0.000129	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—brain cancer	4.73e-06	0.000128	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CG—brain cancer	4.21e-06	0.000114	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—brain cancer	4.09e-06	0.000111	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—brain cancer	4.08e-06	0.00011	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—brain cancer	4.02e-06	0.000109	CbGpPWpGaD
